Carrier Global is rated Buy due to strong demand in data center and commercial HVAC sectors, expanding manufacturing capacity, and improving residential and European markets. Data center orders surged 300% year-over-year in Q2 2026, with revenue expected to double to $2 billion in 2026 and exceed $3 billion in 2027. Residential and light commercial segments are rebounding, supporting profitability alongside long-term aftermarket growth. The stock trades below historical and peer multiples, with earnings per share growth expected to accelerate through 2027, presenting an attractive investment opportunity.
Carrier stock growth is highlighted alongside Pluang's Industrials sector data as of Sep 25, 2026 18:02 WIB. Among 93 priced US Industrials stocks, 70 rose and 20 fell today. Notable movers include VRT at USD 250.50 with a 2.12% gain and a typical hold time of 36 days, contrasting with LUNR at USD 16.02, which rose 2.04% but has a much shorter hold time of 2 days and a Pluang order activity skewed 65% Sell. MTZ stands out with a 2.02% increase at USD 216.23 and a full 100% Buy order activity, showing varied investor interest across these assets.
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
AbbVie and Johnson & Johnson are both strong dividend stocks trading near their 52-week highs, but they differ significantly in risk and growth. AbbVie shows faster revenue growth and a higher dividend yield, driven by its immunology drugs, but faces...
